Moors & Cabot’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,961
| Closed | -$204K | – | 881 |
|
|
2024
Q3 | $204K | Sell |
7,961
-900
| -10% | -$23K | 0.01% | 796 |
|
|
2024
Q2 | $208K | Sell |
8,861
-700
| -7% | -$16.4K | 0.01% | 755 |
|
|
2024
Q1 | $275K | Hold |
9,561
| – | – | 0.01% | 702 |
|
|
2023
Q4 | $314K | Sell |
9,561
-1,550
| -14% | -$50.9K | 0.02% | 615 |
|
|
2023
Q3 | $310K | Sell |
11,111
-30
| -0.3% | -$836 | 0.02% | 591 |
|
|
2023
Q2 | $380K | Sell |
11,141
-20
| -0.2% | -$682 | 0.03% | 526 |
|
|
2023
Q1 | $336K | Sell |
11,161
-400
| -3% | -$12K | 0.02% | 562 |
|
|
2022
Q4 | $326K | Sell |
11,561
-850
| -7% | -$24K | 0.02% | 554 |
|
|
2022
Q3 | $408K | Sell |
12,411
-2,411
| -16% | -$79.3K | 0.03% | 465 |
|
|
2022
Q2 | $467K | Sell |
14,822
-1,413
| -9% | -$44.5K | 0.03% | 431 |
|
|
2022
Q1 | $746K | Sell |
16,235
-2,102
| -11% | -$96.6K | 0.05% | 360 |
|
|
2021
Q4 | $1.12M | Sell |
18,337
-3,782
| -17% | -$232K | 0.07% | 259 |
|
|
2021
Q3 | $1.65M | Sell |
22,119
-5
| -0% | -$373 | 0.1% | 192 |
|
|
2021
Q2 | $2.05M | Buy |
22,124
+2,069
| +10% | +$191K | 0.14% | 153 |
|
|
2021
Q1 | $1.78M | Buy |
20,055
+4,250
| +27% | +$377K | 0.14% | 155 |
|
|
2020
Q4 | $1.48M | Buy |
15,805
+5,487
| +53% | +$512K | 0.12% | 165 |
|
|
2020
Q3 | $657K | Sell |
10,318
-2,914
| -22% | -$186K | 0.06% | 280 |
|
|
2020
Q2 | $690K | Buy |
13,232
+4,078
| +45% | +$213K | 0.07% | 248 |
|
|
2020
Q1 | $286K | Hold |
9,154
| – | – | 0.04% | 387 |
|
|
2019
Q4 | $308K | Buy |
9,154
+792
| +9% | +$26.6K | 0.03% | 457 |
|
|
2019
Q3 | $248K | Buy |
8,362
+500
| +6% | +$14.8K | 0.03% | 499 |
|
|
2019
Q2 | $270K | Buy |
+7,862
| New | +$270K | 0.03% | 436 |
|